Bg pattern

LOPERAMIDE OPKO 2 mg HARD CAPSULES

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use LOPERAMIDE OPKO 2 mg HARD CAPSULES

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the Patient

Loperamide OPKO 2 mg Hard Capsules

Loperamide Hydrochloride

Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.

*Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor, pharmacist, or nurse.

  • Keep this leaflet, you may need to read it again.
  • If you need advice or more information, consult your pharmacist.
  • If you experience side effects, consult your pharmacist, even if it is a side effect not listed in this leaflet. See section 4.
  • You should consult a doctor if it worsens or does not improve after 2 days.

Contents of the Package Leaflet

  1. What is Loperamide OPKO 2 mg Capsules and what is it used for
  2. What you need to know before taking Loperamide OPKO 2 mg Capsules
  3. How to take Loperamide OPKO 2 mg Capsules
  4. Possible side effects
  5. Storage of Loperamide OPKO 2 mg Capsules
  6. Contents of the pack and further information

1. What is Loperamide OPKO 2 mg Capsules and what is it used for

Loperamide is an antidiarrheal that reduces defecations and secretions, resulting in a decrease in liquid stools.

Loperamide is indicated for the symptomatic treatment of acute diarrhea in adults and children over 12 years of age.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before taking Loperamide OPKO 2 mg Capsules

Do not take Loperamide OPKO 2 mg Capsules:

  • Children under 12 years of age
  • If you are allergic to loperamide or any of the other components of this medicine (listed in section 6)
  • If you have a high fever (over 38 °C) and blood in the stool (acute dysentery)
  • If you suffer from ulcerative colitis (inflammation of the intestine)
  • If you suffer from intense diarrhea after taking antibiotics
  • If you suffer from diarrhea caused by an infection caused by a microorganism such as Salmonella, Shigella, or Campylobacter.

Treatment should be stopped quickly and a doctor consulted if constipation, abdominal distension (flatulence), or ileus (absence of defecations) occurs.

Warnings and precautions

Consult your doctor or pharmacist before starting to take Loperamide OPKO 2 mg Hard Capsules

  • If you have intense diarrhea, your body loses more fluids, sugars, and salts than usual. You will need to drink more than usual to replenish fluids. Ask your pharmacist about preparations to replenish sugars and salts
  • If you have AIDS and your stomach swells, stop taking this medicine immediately and consult your doctor
  • If you have any liver disease, consult your doctor before taking this medicine, as it could produce toxicity in the central nervous system.
  • If you have had diarrhea for more than 48 hours, stop taking this medicine and consult your doctor.

Treatment with this medicine is only symptomatic, so the diarrhea should be treated from its cause.

Do not take this medicine for a use other than indicated (see section 1) and never take more than the recommended amount (see section 3). Serious cardiac problems (whose symptoms include rapid or irregular heartbeats) have been reported in patients who have taken an excessive amount of loperamide, the active ingredient of Loperamide OPKO 2 mg Hard Capsules.

Patients with diarrhea should drink plenty of fluids to avoid dehydration, which is manifested by dry mouth, excessive thirst, decreased urine output, wrinkled skin, dizziness, and drowsiness. This is especially important in children and the elderly.

Children and adolescents

Do not use in children and adolescents under 12 years of age.

Other medicines and Loperamide OPKO 2 mg Hard Capsules

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

It is especially important if you are taking medicines that contain

  • Ritonavir, saquinavir (used to treat HIV)
  • Quinidine (used to treat abnormal heart rhythms)
  • Desmopressin oral (used to treat central diabetes insipidus and nocturnal urinary incontinence in children)
  • Itraconazole or ketoconazole (used to treat fungal infections)
  • Gemfibrozil (used to lower cholesterol)

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Pregnant women, especially in the first trimester, should not take this medicine unless prescribed by a doctor.

Do not take Loperamide OPKO 2 mg Hard Capsules if you are breastfeeding. Small amounts of the medicine may pass into breast milk.

Driving and using machines

You can drive and use tools and machines, unless you feel tired, dizzy, or drowsy. Do not drive or use machines in these situations.

Loperamide OPKO 2 mg Hard Capsules contains lactose

If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

3. How to take Loperamide OPKO 2 mg Capsules

Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. In case of doubt, ask your doctor or pharmacist.

The recommended dose is

Adults

  • 2 capsules (4 mg) as an initial dose, followed by 1 capsule (2 mg) after each diarrheal stool.
  • The maximum dose for adults is 8 capsules (16 mg) per day

A one-hour break should be made after the initial dose.

Children over 12 years of age

  • 1 capsule (2 mg) as an initial dose, followed by 1 capsule (2 mg) after each diarrheal stool

The maximum dose in children between 12 and 18 years of age is 4 capsules (8 mg).

A one-hour break should be made after the initial dose.

Treatment should not exceed 48 hours.

Loperamide OPKO 2 mg Hard Capsules should not be used in children under 12 years of age.

Take the capsules with a glass of water.

Patient with liver disease should consult their doctor.

Elderly population

No dose adjustment is necessary in elderly patients.

Kidney problems

No dose adjustment is necessary in patients with renal insufficiency.

Liver problems

If you have liver insufficiency, consult your doctor or pharmacist before taking this medicine.

If you take more Loperamide OPKO 2 mg Capsules than you should

Symptoms

In case of overdose (including relative overdose caused by liver dysfunction), central nervous system depression (stupor, altered coordination, drowsiness, miosis, muscle hypertonia, and respiratory depression), urinary retention, and ileus may occur. Children may be more sensitive to the effects on the central nervous system.

Cardiac events, such as prolonged QT interval and QRS complex, torsades de pointes, other serious ventricular arrhythmias, cardiac arrest, and syncope have been observed in patients who ingested an overdose of loperamide (see section 4.4). Fatal cases have also been reported. Overdose may unmask a pre-existing Brugada syndrome.

Treatment

In cases of overdose, ECG monitoring of the QT interval prolongation should be initiated.

If symptoms of central nervous system overdose occur, naloxone may be administered as an antidote. Since the duration of action of loperamide is longer than that of naloxone (1 to 3 hours), repeated treatment with naloxone may be indicated. Therefore, the patient should be closely monitored for at least 48 hours to detect possible central nervous system depressions.

In case of overdose or accidental ingestion, consult your doctor or pharmacist, or call the Toxicology Information Service, Phone 91 562 04 20 (indicating the medicine and the amount ingested).

If you forget to take Loperamide OPKO 2 mg Capsules

You should only take this medicine when you need it, following the instructions above about the doses.

If you forget to take a dose, take it after the next loose stool.

Do not take a double dose to make up for forgotten doses.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Seek medical attention immediately if you experience any of the following serious side effects:

Serious adverse reactions

Rare:

  • Immune system: hypersensitivity, anaphylactic reaction (including anaphylactic shock), anaphylactoid reaction.
  • Nervous system: loss of consciousness, stupor, altered consciousness, hypertonia, altered coordination.
  • Eyes: miosis
  • Gastrointestinal tract: acute pancreatitis
  • Skin and subcutaneous tissue: bullous eruptions (including Stevens-Johnson syndrome, toxic epidermal necrolysis, and erythema multiforme), angioedema, urticaria, pruritus
  • Kidney and urinary tract: urinary retention

Frequent:

  • Nervous system: headache, dizziness
  • Gastrointestinal tract: constipation, nausea, flatulence

Uncommon:

  • Nervous system: drowsiness
  • Gastrointestinal tract: abdominal pain, abdominal discomfort, dry mouth, upper abdominal pain, vomiting, dyspepsia (including paralytic ileus), megacolon (including toxic megacolon), abdominal distension
  • Skin and subcutaneous tissue: rash

Rare:

  • Symptoms and reactions at the administration site: fatigue

In children and adolescents, the following side effects may also occur:

The side effects observed in children and adolescents in clinical studies were generally similar to those observed in adults and children over 12 years of age.

Reporting of side effects

If you experience any side effect, talk to your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet.

You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Loperamide OPKO 2 mg Capsules

Keep this medicine out of the sight and reach of children.

This medicine does not require any special storage conditions.

Do not use this medicine after the expiry date which is stated on the outer packaging after (EXP). The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help protect the environment.

6. Contents of the pack and further information

Composition of Loperamide OPKO 2 mg Capsules

  • The active substance is loperamide hydrochloride. Each capsule contains 2 mg of loperamide hydrochloride.
  • The other ingredients are lactose monohydrate

The capsule is made of:

Titanium dioxide (E171)

Black iron oxide (E172)

Red iron oxide (E172)

Yellow iron oxide (E172)

Brilliant blue FCF (E133)

Gelatin.

Appearance of the product and pack contents

The loperamide hydrochloride capsule is a hard gelatin capsule of size «4» 14.0 mm to 14.8 mm filled with white to off-white powder with a grey and green cap. Blister packs of aluminum and PVC with 20 hard capsules.

Marketing authorization holder and manufacturer

Marketing authorization holder:

OPKO Health Spain, S.L.U.

Pl. 13-15, 08908

L’Hospitalet de Llobregat (Barcelona)

Spain

Manufacturer:

Meiji Pharma Spain, S.A.

Avda. de Madrid, 94,

Alcalá de Henares,

28802 Madrid,

Spain

Date of last revision of this leaflet: January 2023.

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es

Online doctors for LOPERAMIDE OPKO 2 mg HARD CAPSULES

Discuss questions about LOPERAMIDE OPKO 2 mg HARD CAPSULES, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for LOPERAMIDE OPKO 2 mg HARD CAPSULES?
LOPERAMIDE OPKO 2 mg HARD CAPSULES does not require a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in LOPERAMIDE OPKO 2 mg HARD CAPSULES?
The active ingredient in LOPERAMIDE OPKO 2 mg HARD CAPSULES is loperamide. This information helps identify medicines with the same composition but different brand names.
Who manufactures LOPERAMIDE OPKO 2 mg HARD CAPSULES?
LOPERAMIDE OPKO 2 mg HARD CAPSULES is manufactured by Opko Health Spain S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of LOPERAMIDE OPKO 2 mg HARD CAPSULES online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether LOPERAMIDE OPKO 2 mg HARD CAPSULES is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to LOPERAMIDE OPKO 2 mg HARD CAPSULES?
Other medicines with the same active substance (loperamide) include ABECLIN 2 mg TABLETS, DIARFIN 2 mg HARD CAPSULES, DIARFIN FLAS 2 mg ORAL LYOPHILIZED. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media